CD8A and obesity due to melanocortin 4 receptor deficiency: DC-based immunotherapyReduced efficacy in obese renal carcinoma model, associated with increased regulatory DCs and decreased CD8+ T cells.Potential improved response on combining DC-based immunotherapy with obesity interventions.